#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4358	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2710	332.2	0	.	n	.	0	C451T	SNP	451	451	C	749	749	T	427	T,C	221,87	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4358	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2710	332.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1482	1482	C	536	C,A	373,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4358	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2710	332.2	0	HET	.	.	.	C207T	.	207	207	C	505	505	C	390	C,T	228,56	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4358	16S	1529	1529	99.93	16S.l15.c17.ctg.1	2710	332.2	0	HET	.	.	.	C1450T	.	1450	1450	C	1748	1748	C	555	C,T	304,87	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8040	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4083	397.3	0	.	n	.	0	T695C	SNP	695	695	T	1288	1288	C	596	C,G	397,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8040	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4083	397.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2564	2564	C	511	C	348	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8040	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4083	397.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2638	2638	A	568	A	384	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	8040	23S	2890	2890	99.93	23S.l6.c4.ctg.1	4083	397.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3190	3190	C	503	C	357	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	252	folP	855	855	100.0	folP.l15.c4.ctg.1	1912	26.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1166	1168	AGC	44;44;43	A;G;C	31;31;31	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	664	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3441	39.4	1	SNP	p	S91F	1	.	.	271	273	TTC	473	475	TTC	59;59;59	T;T;C	41;42;42	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	664	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3441	39.4	1	SNP	p	G95N	0	.	.	283	285	GGC	485	487	GGC	63;64;64	G;G;C	45;46;46	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	664	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3441	39.4	1	SNP	p	D95G	1	.	.	283	285	GGC	485	487	GGC	63;64;64	G;G;C	45;46;46	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	27	194	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1641	24.7	1	SNP	p	G45D	0	.	.	133	135	GGC	587	589	GGC	52;52;52	G,A;G;C	32,1;34;34	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	140	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c4.ctg.1	1095	23.6	0	.	n	.	0	A197.	DEL	197	197	A	641	641	A	57	A	39	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	40.6	1	SNP	p	D86N	0	.	.	256	258	GAC	731	733	GAC	47;47;48	G;A;C	33;29;34	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	40.6	1	SNP	p	R87I	0	.	.	259	261	CGT	734	736	CGT	47;49;51	C;G;T	36;35;35	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	40.6	1	SNP	p	R87W	0	.	.	259	261	CGT	734	736	CGT	47;49;51	C;G;T	36;35;35	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	40.6	1	SNP	p	S87R	1	.	.	259	261	CGT	734	736	CGT	47;49;51	C;G;T	36;35;35	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	640	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3260	40.6	1	SNP	p	S88P	0	.	.	262	264	TCC	737	739	TCC	51;50;52	T;C;C	36;37;39	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	558	parE	1986	1986	100.0	parE.l6.c4.ctg.1	3536	33.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	2137	2139	GGC	37;37;37	G;G;C	24;26;22	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	A311V	0	.	.	931	933	GCC	1287	1289	GCC	110;109;111	G;C;C	76;76;78	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	I312M	1	.	.	934	936	ATG	1290	1292	ATG	111;110;110	A;T;G	78;77;77	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	V316T	1	.	.	946	948	ACC	1302	1304	ACC	118;118;116	A;C;C	81;81;79	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	T316P	0	.	.	946	948	ACC	1302	1304	ACC	118;118;116	A;C;C	81;81;79	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1803	1805	ACC	73;75;74	A;C;C	49;47;49	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1857	1859	GCG	63;61;61	G;C,G;G	45;37,1;40	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1857	1859	GCG	63;61;61	G;C,G;G	45;37,1;40	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1980	1982	GGT	59;58;56	G;G;T,G	47;46;45,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1989	1991	AGC	51;51;51	A,G;G;C,G	30,1;36;32,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	738	penA	1746	1746	100.0	penA.l6.c4.ctg.1	2353	62.5	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2007	2009	CCG	45;45;45	C,G;C,T;G,C	32,2;25,1;31,1	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1308	ponA	2397	2397	100.0	ponA.l15.c17.ctg.1	3570	72.9	1	SNP	p	L421P	1	.	.	1261	1263	CCG	2010	2012	CCG	66;66;66	C,G;C;G,C	46,2;52;44,4	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	278	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2117	26.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	680	680	C	28	C	19	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	I45V	NONSYN	133	135	ATT	582	584	GTT	71;68;68	G,A;T,A;T	54,1;50,1;52	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	I75V	NONSYN	223	225	ATT	672	674	GTT	57;57;57	G;T,G;T	43;40,1;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	S89T	NONSYN	265	267	AGC	714	716	ACC	70;70;66	A;C;C	50;50;49	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	I98V	NONSYN	292	294	ATC	741	743	GTC	70;71;71	G;T;C	47;47;48	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	A109V	NONSYN	325	327	GCC	774	776	GTC	66;66;66	G,A;T,G;C	45,1;47,1;48	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	840	842	TAT	57;58;58	T;A;T	44;44;39	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	N134E	NONSYN	400	402	AAT	849	851	GAG	57;57;57	G;A;G	42;42;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	V135L	NONSYN	403	405	GTG	852	854	CTT	57;58;58	C;T;T	43;43;43	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	G140K	NONSYN	418	420	GGA	867	869	AAA	63;63;63	A;A;A	46;46;46	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	Q143G	NONSYN	427	429	CAA	876	878	GGA	64;64;64	G;G,A;A	45;43,1;45	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	478	porB1b	1038	1038	97.59	porB1b.l15.c4.ctg.1	1886	50.7	0	.	p	.	0	V151A	NONSYN	451	453	GTA	900	902	GCA	73;73;73	G;C;A	51;50;51	.	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2142	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5520	80.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	202	rpsJ	312	312	100.0	rpsJ.l6.c4.ctg.1	1277	35.3	1	SNP	p	V57M	1	.	.	169	171	ATG	700	702	ATG	92;91;92	A;T;G	62;64;65	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
